BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2019 related articles for article (PubMed ID: 19300290)

  • 1. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.
    Manzi S; Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Rairie JE; Tracy RP; Kuller LH
    Arthritis Rheum; 1999 Jan; 42(1):51-60. PubMed ID: 9920014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus.
    Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Pratt JE; Tracy RP; Kuller LH; Manzi S
    Arthritis Rheum; 2004 Jan; 50(1):151-9. PubMed ID: 14730611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.
    Shang Q; Tam LS; Li EK; Yip GW; Yu CM
    Lupus; 2008 Dec; 17(12):1096-102. PubMed ID: 19029277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus (SLE).
    Sato H; Miida T; Wada Y; Maruyama M; Murakami S; Hasegawa H; Kuroda T; Narita I; Nakano M; Gejyo F
    Clin Chim Acta; 2007 Oct; 385(1-2):35-42. PubMed ID: 17644082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
    Kiani AN; Magder L; Petri M
    J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of endothelial dysfunction and carotid intima-media thickness in patients undergoing coronary stent implantation.
    Corrado E; Camarda P; Coppola G; Muratori I; Ciaramitaro G; Farinella M; Novo G; Rotolo A; Andolina G; Cospite V; Evola S; Assennato P; Hoffmann E; Novo S
    Int Angiol; 2009 Feb; 28(1):12-9. PubMed ID: 19190550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.
    Meyer AA; Kundt G; Steiner M; Schuff-Werner P; Kienast W
    Pediatrics; 2006 May; 117(5):1560-7. PubMed ID: 16651309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.